Key Moments

WHOOP CEO, Will Ahmed: 50B Hours of Health Data, a 4 Million Member Data Moat, & the FDA Fight

All-In PodcastAll-In Podcast
Entertainment5 min read56 min video
Oct 29, 2026|53,290 views|518|94
Save to Pod
TL;DR

WHOOP's continuous health data is revealing early disease indicators, but their FDA fight over blood pressure monitoring highlights regulatory challenges for innovative wearables.

Key Insights

1

WHOOP users wear the device for an average of 23.6 hours daily, accumulating over 50 billion hours of physiological data.

2

WHOOP's subscription model, initiated in 2017, shifted focus from hardware sales to member retention and continuous product improvement.

3

The platform tracks Sleep, Recovery, and Strain, with advanced features like ECG, AFib detection, blood analysis, and 'Health Age'.

4

WHOOP data has potentially predicted serious health issues, including a case of Hodgkin's lymphoma and another of testicular cancer, by detecting subtle physiological changes.

5

The AI coach, developed internally, provides personalized advice and has learned to assist with complex issues like timezone adjustments for travelers.

6

WHOOP is navigating FDA regulations, facing initial resistance for its Blood Pressure Insights (BPI) feature, which they argued should be classified as 'Public Health' rather than a 'Medical Device'.

The evolution to a subscription model and its impact on product development

WHOOP's journey began with a focus on athletic performance, but in 2017, they pivoted to a subscription model, initially charging $500 for hardware. This decision, driven by high member engagement and a desire for a lower entry price, fundamentally changed the company's focus. Instead of prioritizing new hardware releases every year, WHOOP became obsessed with retaining its existing members. This shift incentivized continuous innovation in software and member experience, leading to the integration of features like ECG, AFib detection, advanced lab analysis, 'Health Age,' and 'Blood Pressure Insights' without requiring users to purchase new devices. This approach contrasts with traditional hardware sales models that often rely on frequent upgrade cycles.

Leveraging 50 billion hours of continuous physiological data for early health detection

With users wearing WHOOP devices for an average of 23.6 hours per day, the company has amassed over 50 billion hours of continuous physiological data, creating one of the largest health datasets globally. This extensive data allows WHOOP to identify subtle physiological signals that may predict health issues before they become symptomatic. For instance, a baseball player with a resting heart rate of 50 bpm experienced a sudden spike to 120-130 bpm during sleep, which led to the diagnosis of Stage IV Hodgkin's lymphoma. Similarly, a user with a consistent Heart Rate Variability (HRV) of 100 suddenly dropped to 50, prompting medical investigation that revealed testicular cancer. This ability to detect anomalies from continuous, passive monitoring positions WHOOP as a powerful tool for proactive health management.

Understanding key metrics: Sleep, Recovery, and Strain

WHOOP's platform is built around three core pillars: Sleep, Recovery, and Strain. Sleep quality is assessed through metrics like sleep duration, deep sleep, REM sleep, and regularity. Recovery, indicated by a red, yellow, or green score out of 100%, reflects the body's readiness for exertion, heavily influenced by factors like sleep, HRV, and resting heart rate. Strain measures the physical exertion of the day. The interplay of these metrics helps users understand how their lifestyle choices impact their physiological state. For example, understanding that late-night meals or alcohol consumption negatively affects sleep and recovery is crucial for optimizing performance and well-being.

The role of the AI coach and personalized insights

WHOOP has integrated an AI coach that enhances the user experience by providing personalized recommendations based on collected data. This coach learns from user interactions and vast datasets to offer tailored advice. For travelers, the AI can predict optimal sleep patterns across timezones, suggesting when to sleep and avoid caffeine to mitigate jet lag. It also helps users understand the impact of specific behaviors, like daily habits or supplement intake, on their recovery and strain scores. For example, the AI can correlate hot baths with a 7% improvement in recovery or highlight the detrimental effects of alcohol and late-night eating.

Navigating FDA regulations and the 'Blood Pressure Insights' controversy

WHOOP has faced regulatory scrutiny, particularly from the FDA, over its 'Blood Pressure Insights' (BPI) feature. Historically, blood pressure monitoring has been classified as a medical device requiring FDA regulation. However, WHOOP argued that BPI, when used to understand the impact of stress, sleep, and lifestyle on blood pressure, falls under 'Public Health' and does not require medical device classification. This led to a warning letter from the FDA. Despite the initial conflict, WHOOP maintained its stance, and the FDA has since updated its guidelines, acknowledging the public health applications of blood pressure monitoring. WHOOP also holds FDA clearance for its ECG feature, demonstrating their ability to navigate different regulatory pathways.

The potential of AI to predict biomarkers and personalize health interventions

With its extensive data, WHOOP is exploring AI's potential to predict physiological biomarkers without direct measurement. By analyzing continuous physiological signals, the AI could potentially forecast abnormal biomarker levels, such as elevated cortisol. This could lead to highly precise recommendations, like suggesting a specific test for a user based on their data. The ongoing development of foundational AI models trained on WHOOP's unique dataset, combined with user-submitted lab results and medical records, aims to create an increasingly sophisticated health prediction engine.

Addressing the challenges of GLP-1 usage and weight management

WHOOP is adapting to emerging health trends, including the use of GLP-1 medications for weight loss. Recognizing that a significant portion of weight lost on GLP-1s can be muscle mass, WHOOP's system can now track GLP-1 usage. This allows the platform to provide more tailored guidance, encouraging sufficient protein intake and strength training to preserve muscle mass. The AI coach can prompt users about their GLP-1 dosage and adherence to recommended lifestyle changes, such as step count, hydration, and protein consumption, aiming to optimize the weight loss journey and mitigate potential side effects.

LeBron James as WHOOP's global ambassador and the company's ethos

The recent announcement of LeBron James as a global ambassador for WHOOP highlights the brand's commitment to top-tier performance and longevity. James has been a WHOOP user for 11 years, embodying the company's philosophy of genuine product love. WHOOP's long-standing policy has been to avoid paying athletes to wear their products, instead relying on authentic adoption by individuals who benefit from the technology. This approach ensures that the athlete is a genuine user, fitting WHOOP's target demographic. This strategy has attracted high-profile investors who are also users, reinforcing the brand's credibility and market position.

WHOOP User Guide: Dos and Don'ts

Practical takeaways from this episode

Do This

Wear your WHOOP device for at least 23.6 hours a day to maximize data collection.
Utilize the daily Sleep, Recovery, and Stress scores to understand your body's status.
Engage with the Journal feature to log behaviors and lifestyle choices for personalized insights.
Consider warm baths for recovery, as they can significantly improve your recovery score.
Ensure adequate protein intake, especially when using weight management drugs like GLP-1.
Prioritize strength training, aiming for at least two sessions per week.
Regularly check your Heart Rate Variability (HRV) as an indicator of nervous system health and longevity.
Leverage the AI coach for personalized advice on sleep, travel, and performance optimization.

Avoid This

Don't rely solely on device readings; pay attention to your body's signals, especially during health scares.
Avoid late-night meals (within three hours of bedtime) as they can negatively impact sleep and recovery.
Be cautious of the alcohol's detrimental effect on your recovery, typically showing a -9% impact.
Don't expect immediate results from supplements like Vitamin D without consistent tracking and correlation.
Be aware of the potential for muscle loss when using weight management drugs like GLP-1; focus on maintaining muscle mass.
Do not wear jewelry during athletic competitions where it is prohibited, opt for the WHOOP armband if allowed.
Avoid engaging with unofficial secondary market brokers claiming to have company shares without verifying with the company's CFO.

Common Questions

WHOOP collects over 50 billion hours of continuous physiological data from users who wear the device for an average of 23.6 hours per day, making it one of the largest health datasets globally.

Topics

Mentioned in this video

Companies
Adidas

A sports apparel company that was part of a generation of wearable tech companies.

Icon Homes

A 3D-printed home company that the host has helped with funding rounds and that is valued in the billions.

Under Armour

A sports apparel company that was part of a generation of wearable tech companies.

Peloton

A fitness platform mentioned for its extensive badge system, similar to WHOOP's gamified achievements.

Lyft

A competitor company mentioned in relation to Masayoshi Son's investment strategies.

Creative Planning

A financial planning service that helps manage investments, tax strategy, and estate planning, offering coordinated teams of specialists.

Google Health

The health division of Google, which Fitbit is now part of.

Jawbone

A former wearable technology company that has exited the market, mentioned in the context of past competitors.

Duane Reade

A pharmacy where the host took a COVID-19 test that came back positive.

Facebook

A company whose secondary market stock activity was noted by the host.

Nike

A sports apparel company that previously had a presence in the wearable technology market but exited.

Figma

A company affected by AI's impact on the market.

Apple

Mentioned in contrast to WHOOP regarding product update cycles and software quality.

Omron

A company that manufactures blood pressure monitors, suggested for WHOOP to integrate with or acquire.

DoorDash

A company affected by AI's impact on the market.

Eight Sleep

A health product that the host is invested in and highly recommends.

WHOOP

A technology company that produces wearable devices focused on optimizing performance and health, collecting physiological data.

Tesla

The host drove a Tesla in self-driving mode to the emergency room during a health scare.

Uber

A company whose secondary market stock activity was noted by the host.

More from All-In Podcast

View all 470 summaries

Ask anything from this episode.

Save it, chat with it, and connect it to Claude or ChatGPT. Get cited answers from the actual content — and build your own knowledge base of every podcast and video you care about.

Get Started Free